• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of Male and Female Prolactinoma Patients Requiring Surgical Intervention.需要手术干预的男性和女性泌乳素瘤患者的比较。
J Neurol Surg B Skull Base. 2018 Aug;79(4):394-400. doi: 10.1055/s-0037-1615748. Epub 2017 Dec 26.
2
Microscopic endonasal transsphenoidal pituitary adenomectomy in the pediatric population.小儿人群的显微镜下经鼻蝶窦垂体腺瘤切除术
J Neurosurg Pediatr. 2011 May;7(5):501-9. doi: 10.3171/2011.2.PEDS10278.
3
Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.直径大于60毫米的巨大催乳素瘤:一组巨大且侵袭性的分泌催乳素垂体腺瘤。
Pituitary. 2016 Aug;19(4):429-36. doi: 10.1007/s11102-016-0723-4.
4
Cure and Hormonal Control After Prolactinoma Resection: Case Series and Systematic Review.催乳素瘤切除术后的治愈与激素控制:病例系列及系统评价
J Endocr Soc. 2021 Apr 28;5(10):bvab074. doi: 10.1210/jendso/bvab074. eCollection 2021 Oct 1.
5
Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas.经鼻内镜垂体腺瘤术后残留或复发的再次手术治疗。
J Neurosurg. 2017 Aug;127(2):397-408. doi: 10.3171/2016.8.JNS152709. Epub 2016 Oct 28.
6
Endoscopic Endonasal Surgery for Tumors of the Cavernous Sinus: A Series of 234 Patients.经鼻内镜手术治疗海绵窦肿瘤:234例病例系列
World Neurosurg. 2017 Jul;103:713-732. doi: 10.1016/j.wneu.2017.04.096. Epub 2017 Apr 24.
7
Comparison of endonasal endoscopic surgery and sublabial microsurgery for prolactinomas.经鼻内镜手术与经唇下显微手术治疗泌乳素瘤的比较。
Surg Neurol. 2002 Dec;58(6):371-5; discussion 375-6. doi: 10.1016/s0090-3019(02)00892-3.
8
Endoscopic endonasal surgery for pituitary tumors. Results in a series of 121 patients operated at the same center and by the same neurosurgeon.经鼻内镜垂体瘤手术。同一中心由同一位神经外科医生为121例患者实施手术的结果。
Endocrinol Nutr. 2014 Oct;61(8):410-6. doi: 10.1016/j.endonu.2014.03.011. Epub 2014 May 20.
9
The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy.多巴胺激动剂治疗时代泌乳素瘤垂体切除术的结果
Clin Endocrinol (Oxf). 1996 Jun;44(6):711-6. doi: 10.1046/j.1365-2265.1996.738559.x.
10
What causes a prolactinoma to be aggressive or to become a pituitary carcinoma?是什么导致泌乳素瘤具有侵袭性或变成垂体癌?
Hormones (Athens). 2012 Oct-Dec;11(4):477-82. doi: 10.14310/horm.2002.1380.

引用本文的文献

1
Outcomes in surgical management of microprolactinomas: an international multi-institutional series.微泌乳素瘤手术治疗的结果:一项国际多机构研究系列
Pituitary. 2025 Feb 3;28(1):28. doi: 10.1007/s11102-025-01497-1.
2
Experience in the Treatment of Male Prolactinomas: A Single-Center, 10-Year Retrospective Study.男性泌乳素瘤的治疗经验:一项单中心10年回顾性研究
Neuroendocrinology. 2024;114(12):1077-1089. doi: 10.1159/000541495. Epub 2024 Sep 27.
3
Gender Differences in Patients with Prolactinoma: Single-center Ukrainian Experience.泌乳素瘤患者的性别差异:乌克兰单中心经验。
Rev Recent Clin Trials. 2024;19(3):204-214. doi: 10.2174/0115748871288948240325080936.
4
Alternations of Blood Pressure Following Surgical or Drug Therapy for Prolactinomas.催乳素瘤手术或药物治疗后的血压变化
Cancers (Basel). 2024 Feb 9;16(4):726. doi: 10.3390/cancers16040726.
5
Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment.泌乳素分泌型垂体腺瘤:发病机制、临床表现和治疗的男性特异性差异。
Front Endocrinol (Lausanne). 2024 Feb 2;15:1338345. doi: 10.3389/fendo.2024.1338345. eCollection 2024.
6
TEMPORAL LOBE HERNIATION AND CHIASMOPATHY DURING DOPAMINE AGONIST THERAPY FOR PROLACTINOMA.多巴胺激动剂治疗泌乳素瘤期间的颞叶疝和视交叉病变
Acta Endocrinol (Buchar). 2023 Jul-Sep;19(3):339-344. doi: 10.4183/aeb.2023.339. Epub 2024 Feb 1.
7
Endoscopic endonasal surgery for prolactinomas: prognostic factors for disease control and management of persistent disease.经鼻内镜手术治疗泌乳素瘤:疾病控制的预测因素和持续性疾病的处理。
Neurosurg Rev. 2023 Nov 9;46(1):295. doi: 10.1007/s10143-023-02199-7.
8
Supervised machine learning to validate a novel scoring system for the prediction of disease remission of functional pituitary adenomas following transsphenoidal surgery.基于监督机器学习验证一种新的评分系统,以预测经蝶窦手术后功能性垂体腺瘤的疾病缓解情况。
Sci Rep. 2023 Sep 16;13(1):15409. doi: 10.1038/s41598-023-42157-3.
9
Gender Disparities in Prolactinomas: Unravelling Clinical Patterns, Metabolic Variations, and Treatment Responses.泌乳素瘤中的性别差异:解析临床模式、代谢变化及治疗反应
Cureus. 2023 Aug 3;15(8):e42911. doi: 10.7759/cureus.42911. eCollection 2023 Aug.
10
Influence of gender and sexual hormones on outcomes after pituitary surgery: a systematic review and meta-analysis.性别和性激素对垂体手术后结局的影响:系统评价和荟萃分析。
Acta Neurochir (Wien). 2023 Sep;165(9):2445-2460. doi: 10.1007/s00701-023-05726-z. Epub 2023 Aug 9.

本文引用的文献

1
Diagnosis and Treatment of Pituitary Adenomas: A Review.垂体腺瘤的诊断与治疗:综述
JAMA. 2017 Feb 7;317(5):516-524. doi: 10.1001/jama.2016.19699.
2
Sex differences in the development of prolactinoma in mice overexpressing hCGβ: role of TGFβ1.过表达hCGβ的小鼠催乳素瘤发生中的性别差异:转化生长因子β1的作用
J Endocrinol. 2017 Mar;232(3):535-546. doi: 10.1530/JOE-16-0371. Epub 2017 Jan 17.
3
THERAPY OF ENDOCRINE DISEASE: Surgery in microprolactinomas: effectiveness and risks based on contemporary literature.内分泌疾病的治疗:微泌乳素瘤的手术治疗:基于当代文献的疗效与风险
Eur J Endocrinol. 2016 Sep;175(3):R89-96. doi: 10.1530/EJE-16-0087. Epub 2016 May 20.
4
Reasons and results of endoscopic surgery for prolactinomas: 142 surgical cases.泌乳素瘤的内镜手术原因及结果:142例手术病例
Acta Neurochir (Wien). 2016 May;158(5):933-42. doi: 10.1007/s00701-016-2762-z. Epub 2016 Mar 12.
5
Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth.雌激素受体α的表达与催乳素垂体瘤预后相关,并支持肿瘤生长中的性别差异。
Eur J Endocrinol. 2015 Jun;172(6):791-801. doi: 10.1530/EJE-14-0990. Epub 2015 Mar 19.
6
Outcomes of endoscopic transsphenoidal pituitary surgery.内镜经蝶窦垂体手术的结果
Endocrinol Metab Clin North Am. 2015 Mar;44(1):105-15. doi: 10.1016/j.ecl.2014.10.010. Epub 2014 Nov 4.
7
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.高泌乳素血症的诊断和治疗:内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2011 Feb;96(2):273-88. doi: 10.1210/jc.2010-1692.
8
Dopamine agonist-resistant prolactinomas.多巴胺激动剂抵抗型催乳素瘤。
J Neurosurg. 2011 May;114(5):1369-79. doi: 10.3171/2010.11.JNS101369. Epub 2011 Jan 7.
9
Gender differences in macroprolactinomas: study of clinical features, outcome of patients and ki-67 expression in tumor tissue.巨泌乳素瘤中的性别差异:临床特征、患者预后及肿瘤组织中 ki-67 表达的研究。
Front Horm Res. 2010;38:50-58. doi: 10.1159/000318494. Epub 2010 Jul 5.
10
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.男性雄激素缺乏综合征的睾酮治疗:内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2010 Jun;95(6):2536-59. doi: 10.1210/jc.2009-2354.

需要手术干预的男性和女性泌乳素瘤患者的比较。

Comparison of Male and Female Prolactinoma Patients Requiring Surgical Intervention.

作者信息

Yoo Frederick, Chan Carmen, Kuan Edward C, Bergsneider Marvin, Wang Marilene B

机构信息

Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, United States.

Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, United States.

出版信息

J Neurol Surg B Skull Base. 2018 Aug;79(4):394-400. doi: 10.1055/s-0037-1615748. Epub 2017 Dec 26.

DOI:10.1055/s-0037-1615748
PMID:30009121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6043172/
Abstract

Prolactinomas are the most common functional pituitary adenoma. Symptoms of a prolactinoma stem from hormonal causes (menstrual irregularities, galactorrhea, and reduced libido) or from tumor mass effect (visual changes and headache). Gender differences have been noted in prolactinomas, with males presenting with larger tumors and sequelae of mass effect, while females present commonly with hormonal symptoms. The purpose of this study is to evaluate differences in patient and disease characteristics, and outcomes between male and female prolactinoma patients undergoing surgery.  This was a retrospective chart review.  This was done at the tertiary medical center.  The medical records of prolactinomas patients who underwent endoscopic endonasal surgery between March 2008 and August 2016 were reviewed.  Demographic information, tumor characteristics, and treatment characteristics and outcomes were collected. Statistical analysis was performed using chi-squared test or Student's -test as applicable.  Seventy-nine patients were identified, 22 males and 57 females. The average age for males was 38 years and for females was 35 years. Males were more likely to present with decreased libido (  < 0.0001), whereas females more often presented with galactorrhea (  < 0.0001) and menstrual irregularities. Tumor size was larger in males (  = 0.0044) with higher likelihood of suprasellar extension (  = 0.0409) and cavernous sinus invasion (  = 0.0026). Males were more likely to have a subtotal resection rather than gross total resection (  = 0.0086) and less likely to have normalization of prolactin levels following surgery (  = 0.0019)  Male prolactinoma patients tend to have larger tumors with more aggressive features. This may have a role in the differences in outcomes noted in this study.

摘要

泌乳素瘤是最常见的功能性垂体腺瘤。泌乳素瘤的症状源于激素原因(月经不调、溢乳和性欲减退)或肿瘤占位效应(视力变化和头痛)。泌乳素瘤存在性别差异,男性患者肿瘤较大且有占位效应的后遗症,而女性通常表现为激素症状。本研究的目的是评估接受手术的男性和女性泌乳素瘤患者在患者和疾病特征以及治疗结果方面的差异。

这是一项回顾性病历审查。

研究在三级医疗中心进行。

回顾了2008年3月至2016年8月期间接受鼻内镜手术的泌乳素瘤患者的病历。

收集了人口统计学信息、肿瘤特征、治疗特征和治疗结果。根据适用情况使用卡方检验或学生t检验进行统计分析。

共确定了79例患者,其中男性22例,女性57例。男性的平均年龄为38岁,女性为35岁。男性更易出现性欲减退(P<0.0001),而女性更常出现溢乳(P<0.0001)和月经不调。男性的肿瘤体积更大(P = 0.0044),向鞍上扩展(P = 0.0409)和海绵窦侵袭(P = 0.0026)的可能性更高。男性更有可能接受次全切除而非全切除(P = 0.0086),术后泌乳素水平恢复正常的可能性较小(P = 0.0019)。

男性泌乳素瘤患者往往肿瘤更大,具有更具侵袭性的特征。这可能是本研究中观察到的治疗结果差异的原因之一。